Wonhee Woo
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Wonhee Woo’s office at (408) 972-3380 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A170228 · Current
Licensed to practise in California · since 2020 · expires 2028-09-30 · State University of New York Health Science Center at Brooklyn.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Allergy and Immunology - Allergy and Immunology
- American Board of Internal Medicine - Internal Medicine
Medicaid work
$424 in 2024
Medicaid paid $424 for 50 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 50 | $424 |
| 2024 | 50 | 1 | 13 | $424 |
Drugs they prescribed that Part D paid
$30,077
Pharmacies billed $30,077 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 321) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
267 generic and 54 brand-name prescriptions · $30,077 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Breyna | 32 | $10,204 | $319 |
| Spiriva Respimat | 18 | $9,875 | $549 |
| Ipratropium | 85 | $1,867 | $22 |
| Azelastine | 65 | $1,098 | $17 |
| Fluticasone Propionate | 40 | $899 | $22 |
See all 6 drugs
| Breyna | 32 | $10,204 | $319 |
| Spiriva Respimat | 18 | $9,875 | $549 |
| Ipratropium | 85 | $1,867 | $22 |
| Azelastine | 65 | $1,098 | $17 |
| Fluticasone Propionate | 40 | $899 | $22 |
| Albuterol Sulfate Hfa | 17 | $276 | $16 |
Year by year
| 2024 | 321 | 107 | 0% (0) | 17% | $30,077 |
| 2023 | 213 | 74 | 0% (0) | 30% | $30,140 |
| 2022 | 25 | 16 | 0% (0) | 44% | $2,979 |
| 2019 | 68 | 16 | 0% (0) | None | $2,249 |
| 2018 | 115 | 41 | None | None | $3,482 |
| 2017 | 12 | None | 0% (0) | None | $854 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Symbicort | 27 | $16,898 | $626 |
| Ipratropium | 39 | $1,332 | $34 |
| Azelastine | 36 | $620 | $17 |
| Fluticasone Propionate | 33 | $489 | $15 |
| Albuterol Sulfate Hfa | 22 | $351 | $16 |
| Triamcinolone Acetonide | 11 | $140 | $13 |
Money from drug and device companies
$880 in 2022
| 2022 | 8 | 10 | None | $880 |
| 2021 | 7 | 12 | None | $1,103 |
| 2020 | 2 | 2 | None | $41 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Grifols USA | Prolastin-C Liquid | $207 | 2 payments
|
| Pfizer | None | $129 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | None | $107 | 1 payment
|
| Genzyme | None | $105 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Tezspire | $100 | 1 payment
|
| Horizon Therapeutics plc | Actimmune | $87 | 1 payment
|
See all 10 published payments
| Pfizer | Meals · 2022-06-09 | None | $129 |
| Grifols USA | Meals · 2022-05-04 | Xembify | $89 |
| Genentech | Meals · 2022-04-21 | Xofluza | $65 |
| Genzyme | Meals · 2022-04-19 | None | $105 |
| Baxter Healthcare | Meals · 2022-04-13 | Hillrom - Life 2000 Ventilation System | $63 |
| Genentech | Meals · 2022-04-13 | Xofluza | $18 |
| Horizon Therapeutics plc | Meals · 2022-02-26 | Actimmune | $87 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2022-02-25 | None | $107 |
| AstraZeneca Pharmaceuticals LP | Meals · 2022-02-17 | Tezspire | $100 |
| Grifols USA | Meals · 2022-01-20 | Prolastin-C Liquid | $118 |
See earlier years (2021, 2020)
2021: $1,103
| Regeneron Healthcare Solutions | Dupixent | $382 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $227 | 2 payments
|
| Pharming Healthcare | Ruconest | $196 | 2 payments
|
| BioCryst US Sales Co. | Orladeyo | $110 | 1 payment
|
| Sanofi-Aventis U.S. | Dupixent | $93 | 1 payment
|
| GlaxoSmithKline | Nucala | $72 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Cuvitru | $24 | 1 payment
|
2020: $41
| kaleo | Auvi-Q | $24 | 1 payment
|
| CSL Behring | Hizentra | $18 | 1 payment
|
Professional record
- NPI
- 1851824817
- Licence
- CA A170228California A170228: Current · expires 2028-09-30
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 2112 Market St Apt 211, San Francisco, CA, 94114
- NPI first listed
- 2017-04-06
- NPI last updated
- 2022-08-08
- NPI record certified
- 2022-08-08
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.